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Introduction: Lysine is the first limiting essential amino acid in the diet of newborns. First pass metabolism
by the intestine of dietary lysine has a direct effect on systemic availability. We investigated whether first
pass lysine metabolism in the intestine is high in preterm infants, particularly at a low enteral intake.
Patients and methods: Six preterm infants (birth weight 0.9 (0.1) kg) were studied during two different
periods: period A (n = 6): 40% of intake administered enterally, 60% parenterally; lysine intake 92
(6) mmol/(kg6h); and period B (n = 4): 100% enteral feeding; lysine intake 100 (3) mmol/(kg6h). Dual
stable isotope tracer techniques were used to assess splanchnic and whole body lysine kinetics.
Results: Fractional first pass lysine uptake by the intestine was significantly higher during partial enteral
feeding (period A 32 (10)% v period B 18 (7)%; p,0.05). Absolute uptake was not significantly different.
Whole body lysine oxidation was significantly decreased during full enteral feeding (period A 44 (9) v
period B 17 (3) mmol/(kg6h); p,0.05) so that whole body lysine balance was significantly higher during
full enteral feeding (period A 52 (25) v period B 83 (3) mmol/(kg6h); p,0.05).
Conclusions: Fractional first pass lysine uptake was much higher during partial enteral feeding. Preterm
infants receiving full enteral feeding have lower whole body lysine oxidation, resulting in a higher net
lysine balance, compared with preterm infants receiving partial enteral feeding. Hence parenterally
administered lysine is not as effective as dietary lysine in promoting protein deposition in preterm infants.
T
he primed constant intravenous infusion of amino acids
labelled with stable isotopes has become the reference
method for studying whole body protein dynamics.1–3 By
measuring oxidation rates of specific amino acids directly,
conclusions can be drawn on the excessive supply of a
particular amino acid. Because of limitations in studying
nutrient metabolism in preterm neonates, several studies in
neonatal animals have been performed to quantify protein
metabolism in vivo. These studies have shown that the portal
drained viscera (intestines, pancreas, spleen, and stomach)
utilise more than 50% of dietary protein intake for protein
synthesis and biosynthetic pathways,4–7 and is a major site of
lysine oxidation.8 Of particular importance is the utilisation
rate by the intestine of essential amino acids. A high
utilisation rate of essential amino acids by the intestine
results in lower systemic availability of essential amino acids.
We were specifically interested in lysine, which is the first
limiting amino acid in milk fed mammalian newborns.9 Thus
if the amount of protein in the diet is not adequate, the rate
of protein synthesis and growth will be determined by the
amount of lysine.
The neonatal piglet is generally considered to be a good
model for the human infant with respect to rate and pattern
of gastrointestinal tract development.10 In addition, amino
acid patterns are similar between piglets and infants in terms
of both plasma concentrations and requirements.11 12
However, there are no data on lysine kinetics in infants
while in adults splanchnic lysine uptake has been found to
vary between 5% and 35% of lysine intake.7 13
Largely as a result of their immature gastrointestinal tract,
all preterm infants face a period of compromised enteral
intake in their first weeks of life, and they frequently receive
a combined parenteral and enteral nutrient supply. Based on
our finding that absolute lysine utilisation by the intestine of
neonatal pigs appears to be independent of lysine intake,8 we
postulated that fractional first pass lysine utilisation would
be much higher during a restricted enteral intake.
Importantly, this would result in a lower systemic availability
of dietary lysine. Therefore, we measured first pass lysine
uptake in response to two different enteral intakes in
neonates.
Apart from first pass lysine utilisation, the magnitude of
intestinal lysine catabolism is also important to the nutrition
of preterm newborns. The energy needed to sustain the high
rate of protein turnover in the gut is largely derived from
oxidation of non-essential amino acids.4 14 However, some
essential amino acids, including lysine, are also oxidised,
which leads to irreversible loss.8 15 16 Despite the general belief
that the intestinal mucosa does not possess lysine catabolic
enzymes,17 18 we showed that intestinal oxidation of dietary
lysine in pigs accounted for approximately 30% of whole body
lysine oxidation.6 Whether dietary lysine is oxidised by
splanchnic tissues in humans has not yet been investigated.
Quantification of the response of splanchnic and whole body
lysine oxidation on the level of enteral protein intake in
preterm infants was the second objective of this study.
METHODS
Patients
The study protocol was approved by the Erasmus University
Institutional Review Board. Written informed consent was
obtained from parents. Splanchnic and whole body lysine
kinetics were quantified in preterm infants during partial
enteral feeding (period A) and full enteral feeding (period B).
Patients eligible for this study were premature infants with a
birth weight ranging from 750 g to 1250 g who were
appropriate for gestational age according to the charts of
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: LRP, lysine release from protein breakdown; NOLD,
non-oxidative lysine disposal; PDB, Pee Dee Belemnite
38
www.gutjnl.com
 on 7 November 2006 gut.bmjjournals.comDownloaded from 
Usher and McLean.19 Excluded from the study were infants
who had congenital anomalies, or gastrointestinal or liver
diseases. CRIB scores20 on the first day of life were all below
5. The clinical characteristics of the neonates are shown in
table 1. They received a nutrient regimen according to our
feeding protocol: a combination of breast feeding or formula
(Nenatal; Nutricia, Zoetermeer, the Netherlands) and par-
enteral nutrition containing glucose, amino acids (Primene
10%; Clintec Benelux NV, Brussels, Belgium), and lipids
(Intralipid 20%; Fresensius Kabi, Den Bosch, the
Netherlands). Nenatal was given as sole enteral nutrition
12 hours before the start of the study and during the study
days.
Protocol
The study design consisted of two periods of two consecutive
study days (period A—study days 1 and 2, and period B—
study days 3 and 4) (fig 1). During period A, infants received
40% enteral and 60% parenteral feeding, and during period B
they received full enteral feeding. During period A, infants
were implanted with both an arterial and intravenous
catheter for infusion of tracers and withdrawal of blood
samples. During period B, a peripheral intravenous catheter
was available for infusion of tracers; blood samples were
collected by heelstick. Withdrawing blood via a heelstick is
obtaining blood from arterial capillaries while the heel is
heated before collection to ensure easy collection. We assume
that similar to the heated hand box technique, there is no
difference in plasma enrichment.21
In order to collect breath samples from these infants, we
used the method described by Perman et al who used a nasal
tube.22 This method has been used in children22 and preterm
infants for collection of expiratory CO2 recovery after admin-
istration of 13C labelled substrates.23 24 We have validated this
technique for the use of oxidation studies in preterm infants
(Van der Schoor, unpublished data). Briefly, a 6 Fr gastric
tube (6 Ch Argyle; Sherwood Medical, Tullamore, Ireland)
was placed 1–1.5 cm into the nasopharynx, and a sample of
15 ml end tidal breath was taken slowly with a syringe.
Duplicate aliquots of expired air from each sampling point
were stored in vacutainers for analysis.
Three different stable isotope infusions were performed
during each study day. Firstly, a primed two hour infusion
(10.02 mmol/kg and 10.02 mmol/(kg6h)) of [13C]bicarbonate
Table 1 Subject characteristics
Patient No GA (weeks) Sex
Birth weight
(kg) CRIB score
Postnatal age
period A (days)
Postnatal age
period B (days)
Study weight
period A (kg)
Study weight
period B (kg)
1 26 M 1.05 2 7 39 1.1 1.5
2 30 M 0.92 1 11 22 0.9 1.0
3 29 M 1.24 2 5 12 1.1 1.5
4 31 F 1.22 1 4 9 1.1 1.2
5 29 M 0.95 4 10 0.8
6 26 M 0.90 1 5 0.9
Mean (SD) 29 (2) 0.9 (0.3) 2 (2) 7 (4) 21 (13) 1.0 (0.1) 1.3 (0.2)
GA, gestational age.
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Figure 1 Schematic overview of study days 1 and 2 during period A, and study days 3 and 4 during period B.
Lysine kinetics in preterm infants 39
www.gutjnl.com
 on 7 November 2006 gut.bmjjournals.comDownloaded from 
(99.0 mol% 13C; Cambridge Isotopes, Woburn,
Massachusetts, USA) dissolved in sterile saline was adminis-
tered at a constant rate. The 13C labelled bicarbonate infusion
was immediately followed by two primed five hour infusions
(9.77 mmol/kg and 9.77 mmol/(kg6h)) of [U-13C]lysine
(97.0 mol% 13C; Cambridge Isotopes) and (9.31 mmol/kg
and 9.31 mmol/(kg6h)) of [2H4]lysine (98.0 mol%
2H;
Cambridge Isotopes). During both periods A and B, we
administered the tracers in the following order: on study days
1 and 3, [U-13C]lysine was given via an intravenous catheter
and [2H4]lysine via the intragastric catheter; on study days 2
and 4, the intravenous and intragastric routes were switched.
All isotopes were tested and found to be sterile and pyrogen
free before use in our studies. At time 0, baseline blood and
breath samples were collected. During the last hour of each
tracer infusion, breath samples were collected at 15 minute
intervals and blood samples were obtained at 390 and
420 minutes. The total amount of blood withdrawn during
a study day was 1.5 ml, which is less than 2% of blood
volume in a 1000 g infant. Blood was centrifuged immedi-
ately and stored at 270 C˚ for further analysis.
Analytical methods
Small aliquots of plasma (100 ml) were taken for measure-
ment of plasma lysine concentrations by an Amino Acid
Analyser (Biochrom Ltd, Cambridge, UK). Enrichment of
[U-13C]lysine and [2H4]lysine in plasma was determined by
gas chromatography-mass spectrometry as the N(O,S)-
methoxycarbonylmethylester derivative according to
Husek,25 with minor modifications. Breath samples were
analysed for enrichment of 13CO2 on an isotope ratio mass
spectrometer (ABCA; Europa Scientific, Van Loenen
Instruments, Leiden, the Netherlands).26
Calculations
The rate of lysine turnover was calculated by measuring
tracer dilution at steady state as modified for stable isotope
tracers, as previously described.27 28 The equations used to
obtain the results are detailed in the appendix.
Statistics
Data are expressed as mean (SD) values obtained from
samples taken over the last hour of each tracer infusion.
Statistical comparisons were performed using the Student’s t
test. A value of p,0.05 was taken as statistically significant.
RESULTS
Six patients were studied during period A and four during
period B (table 1). Body weight at the time of period A was
1.0 (0.1) kg and 1.3 (0.2) kg during period B. All infants were
clinically stable with no clinical signs of septicaemia. Routine
blood chemistry and haematology were all within normal
limits, and there were no significant changes in these
parameters 24 hours before and after the study. During
period A, five of six infants received supplemental oxygen by
a nasal prong, while during period B none of the four infants
needed supplemental oxygen. Mean lysine, protein, glucose,
fat, and energy intakes during periods A and B are presented
in table 2.
Isotopic plateau
Lysine kinetics were calculated from the plateau enrichment
values for plasma lysine and breath carbon dioxide (table 3).
Background recovery of the [13C]label in expiratory air was
not significantly different between both periods (period A
219.80 (1.28) v period B 220.24 (0.99) 13C Pee Dee
Belemnite (PDB)). There was also no difference in back-
ground recovery of the [13C]label in expiratory air between
the two consecutive study days of each period (A: day 1:
220.61 (1.23) v day 2: 218.99 (1.43) PDB; and B: day 1:
221.58 (0.35) v day 2:218.89 (2.59) PDB). Although we took
two blood samples after four hours of tracer infusion, we are
sure that steady state was reached as we found an isotopic
plateau in CO2 excretion. Before a plateau in breath is
reached, a plateau has to be reached at the site of lysine
oxidation (that is, intracellularly). 13CO2 enrichment in
breath during [13C]sodium bicarbonate infusion rose rapidly
during the first hour of infusion in both periods, to become
constant in all infants by 120 minutes, with ,5% variation in
the plateau (period A 4.1 (1.0) v period B 3.4 (0.8)%). The
coefficient of variation of breath [13C]lysine enrichment
above baseline at plateau was 6.2 (1.5)% during period A and
6.8 (1.6)% during period B.
Lysine kinetics
Plasma lysine concentration was significantly higher during
partial enteral feeding compared with full enteral feeding
(period A 231 (108) v period B 133 (48) mmol/(kg6h);
p,0.05). As expected, whole body lysine fluxes were higher
for the oral than for the intravenous tracer group during both
periods (period A flux intragastric 396 (49) v flux intravenous
267 (35) mmol/(kg6h); period B flux intragastric 279 (42) v
flux intravenous 231 (40) mmol/(kg6h)). First pass lysine
uptake as a fraction of dietary lysine intake was significantly
higher during restricted enteral lysine intake (period A 32
(10) v period B 18 (7)%; p,0.05). However, splanchnic lysine
uptake in absolute amounts was not significantly different
during full enteral intake (period A 10 (3) v period B 18
Table 2 Lysine, protein, carbohydrate, fat, and energy intakes during periods A and B
Period A Period B
Total lysine intake (mmol/(kg6h)) 92 (13) 100 (6)
Enteral 33 (5) 100 (6)
Parenteral 59 (15) —
Total protein intake (g/(kg6day)) 3.4 (0.3) 3.5 (0.2)
Enteral 1.2 (0.2) 3.5 (0.2)
Parenteral 2.2 (0.6) —
Total carbohydrate intake (g/(kg6day)) 10.6 (2.2) 11.5 (0.7)
Enteral 3.7 (0.6) 11.5 (0.7)
Parenteral 6.9 (2.0) —
Total fat intake (g/(kg6day)) 4.1 (0.9)* 6.5 (0.4)
Enteral 2.0 (0.3) 6.5 (0.4)
Parenteral 2.0 (0.9) —
Total energy intake (kcal/(kg6day)) 92 (11)* 123 (4)
Enteral 38 (7) 123 (4)
Parenteral 52 (10) –
Values are means (SD); n = 6 in period A and n = 4 in period B.
*p,0.05.
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(6) mmol/(kg6h); p = 0.17). Splanchnic tissues did not
oxidise dietary lysine during partial enteral feeding or during
full enteral feeding (period A 24 (23) v period B 218
(20) mol/(kg6h)).
Whole body lysine oxidation was significantly lower during
full enteral feeding (fig 2). Whole body lysine oxidation
accounted for 50 (19)% of total lysine intake during partial
enteral nutrition whereas only 17 (3)% of total lysine intake
was oxidised during full enteral feeding (p,0.05). The non-
oxidative disposal of lysine (NOLD; period A 222 (36) v period
B 169 (36) mmol/(kg6h)) and lysine release of protein
breakdown (LRP; period A 214 (39) v period B 131
(38) mmol/(kg6h)) were not significantly different during
both periods. The resulting net lysine balance was signifi-
cantly higher during full enteral feeding (fig 2).
DISCUSSION
The main purpose of this study was to measure lysine
kinetics in preterm infants to gain insight into the
importance of splanchnic tissues in relation to whole body
lysine kinetics. In addition, we wished to quantify first pass
lysine metabolism during both full enteral feeding and
significantly lower enteral intake. Our data demonstrated
that in preterm infants receiving full enteral feeding, whole
body lysine oxidation was significantly lower and lysine
balance significantly higher than in preterm infants receiving
partial enteral feeding. Approximately one third of dietary
lysine is removed by the splanchnic region during partial
enteral feeding compared with a lower fraction (18%) during
full enteral feeding. Furthermore, we could not detect any
first pass lysine oxidation by splanchnic tissues in either
feeding period.
It is of interest to note our results in neonatal pigs receiving
a low protein diet,6 with regard to the high fractional first
pass lysine uptake observed under a restricted enteral amino
acid supply in preterm infants. The high splanchnic extrac-
tion as a fraction of dietary intake in preterm infants
receiving partial enteral feeding is also consistent with the
high values for protein turnover observed in immature rats,29
with a maximal contribution of the intestine to whole body
protein synthesis attained at weaning.
A high first pass uptake may also be caused by incomplete
digestion and absorption of dietary proteins and amino acids.
However, studies in adults and infants have shown a high
digestibility of approximately 98% of milk proteins and cereal
protein.30 31 This indicates that probably all dietary milk
proteins are absorbed by the intestinal mucosa and are not
lost in faeces. Thus lysine that does not appear in the
systemic circulation is utilised by the intestine, and is not lost
via faeces. Indeed, Stoll et al have demonstrated in neonatal
pigs that splanchnic tissues have high requirements for
amino acids and are proving to be an important modulator of
whole body amino acid availability.6 High splanchnic lysine
extraction in preterm infants in their first weeks of life may
be necessary to provide amino acids for their high intestinal
protein synthesis during a period of rapid adaptation to
enteral feeding. It is well known, for example, that the
presence of nutrients in the intestinal lumen provides a
marked stimulus to intestinal growth.32
In contrast with our finding in piglets, intraluminal lysine
or lysine taken up by splanchnic tissues is apparently not
oxidised, implying that intestinal lysine metabolism in
preterm infants only includes protein synthesis. In other
words, these results suggest that the premature gut has a
Table 3 Baseline and steady state plasma isotopic enrichments on study days 1 and 2
during period A and on study days 3 and 4 during period B
Study
day
[U-13C]lysine [2H4]lysine
Baseline Plateau Baseline Plateau
(mol%) (mol%) (mol%) (mol%)
1 0.0010 (0.0006) 0.0345 (0.0042) 0.0019 (0.0008) 0.0201 (0.0045)
2 0.0019 (0.0007) 0.0315 (0.0040) 0.0042 (0.0019) 0.0360 (0.0067)
3 0.0018 (0.0005) 0.0372 (0.0100) 0.0028 (0.0008) 0.0324 (0.0061)
4 0.0059 (0.0065) 0.0362 (0.0074) 0.0031 (0.0005) 0.0461 (0.0094)
Values are means (SD); n = 6 on study days 1 and 2 and n = 4 at study days 3 and 4.
On study days 1 and 3 [U-13C]lysine was administered by intravenous infusion and [2H4]lysine by intragastric
infusion, and on study days 2 and 4 [U-13C]lysine was given by intragastric infusion and [2H4]lysine by intravenous
infusion.
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Figure 2 Whole body lysine oxidation and balance in absolute amounts during period A (n = 6) and period B (n = 4). *p,0.05.
Lysine kinetics in preterm infants 41
www.gutjnl.com
 on 7 November 2006 gut.bmjjournals.comDownloaded from 
most efficient use of the essential amino acid lysine, and
plays an important role in channelling dietary amino acids to
peripheral tissues.
Our second aim was to determine whole body lysine
kinetics in relation to two different enteral lysine supplies.
Surprisingly, in preterm infants on full enteral feeding, whole
body lysine oxidation was significantly lower in comparison
with partial enteral feeding. Decreased whole body lysine
oxidation suggests a protein sparing mechanism during full
enteral feeding in preterm infants. Consequently, lysine
balance increased significantly as dietary lysine intake was
augmented. In concordance with these oxidation results,
plasma lysine concentration was significantly higher during
partial enteral feeding. During this feeding period, amino
acids were administered via both the venous circulation and
the stomach, in contrast with full enteral feeding. The higher
plasma lysine concentration during partial enteral feeding
may be a result of our direct intravenous infusion and
significantly lower first pass lysine uptake by the gut. In
addition, lower whole body lysine oxidation during partial
enteral feeding may have contributed to a higher plasma
lysine level. Another explanation for this observation may be
that total amino acid intake was nutritionally better balanced
during full enteral feeding, which resulted in an improved
lysine balance. In other words, it might indicate that lysine is
not the first limiting essential amino acid in the diet under
the conditions of partial enteral feeding. Otherwise, lysine
oxidation would have been lower during partial enteral
feeding.
The apparent lower whole body lysine oxidation and higher
lysine balance during full enteral feeding were similar to
values obtained by Duffy and Pencharz.33 Their study
compared the effect of feeding route (intravenous or enteral)
on protein metabolism of the neonate and concluded that
orally fed neonates utilise amino acids for synthesis more
efficiently than total parenterally fed infants.33 Early par-
enteral supply of amino acids is given to prevent protein loss
but the present study clearly shows that enteral feeding is a
far more efficient way of feeding preterm infants.
Unfortunately, intestinal immaturity often impairs early full
enteral feeding but our data suggest that maximal effort
should be paid to initiate enteral feeding as soon as possible
in preterm infants.34
There were some limitations in our study design. Energy
intake is one of the factors that influence protein synthesis
rate. Although lysine intakes during both feeding periods
were almost identical, energy intake was significantly
different between the feeding periods. Intake of metabolic
energy by partial enterally fed infants was 74% of the intake
of enterally fed infants. Parenterally fed neonates appear to
require only 75% of the energy of enterally fed infants to
achieve the same growth rate35 because of the lower energy
expenditure of the splanchnic tissues during parenteral
nutrition. In addition, enterally fed infants have some energy
losses in stool due to malabsorption. In a previous study, we
found no significant effect of reducing energy intake from
120 to 100 kcal/(kg6day) on nitrogen excretion and protein
deposition in preterm infants.36 Van Goudoever et al showed
in preterm infants that the overall pattern of fuel utilisation
was unaffected by the mode of feeding.37 Therefore, we
speculate that the higher energy intake during full enteral
feeding did not significantly influence lysine kinetics.
Another issue relevant to the study design is the different
postnatal ages at both study periods. Infants were older
during period B, which may have influenced lysine kinetics.
However, it was not feasible in our study design to have
infants on full enteral feeding on day 7. On the other hand, it
was not ethically justified to have infants on partial enteral
feeding at a postnatal age of three weeks for a period of at
least five days in order for them to adjust to a reduced enteral
feeding rate. In addition, we wanted to evaluate lysine
kinetics in preterm infants who were treated according to
standard neonatal intensive care feeding regimens.
In conclusion, we have shown that splanchnic tissues have
a high rate of metabolism and use almost one third of dietary
lysine intake in preterm infants undergoing partial enteral
feeding. However, although lysine is catabolised by the whole
body to a great extent, especially during partial enteral
feeding, it is not catabolised by splanchnic tissues during first
pass in preterm infants. Furthermore, lysine balance was
much higher during full enteral feeding compared with
partial enteral feeding. Taken together, the results indicate
that parenterally administered lysine is not as effective as
dietary administered lysine in promoting protein deposition
in preterm infants in their first weeks of life.
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APPENDIX
Lysine flux was calculated as:
Qiv = iL6[(Ei/Ep)21] (1)
where Qiv is flux of the intravenous lysine tracer (mmol/
(kg6h)), iL is the lysine infusion rate (mmol/kg6h)), and Ei and
Ep are the enrichments (mol% excess) of [U-
13C or 2H4]lysine in
the lysine infusate and in plasma at steady state, respectively.
First pass lysine uptake was calculated as:
U = [(Qig2Qiv)/Qig]6I (2)
where U is first pass lysine uptake (mmol/(kg6h)), Qig is flux
of the intragastric lysine tracer (mmol/(kg6h)), and I is
enteral lysine intake (mmol/(kg6h)).
At steady state, the amount of lysine entering the plasma
pool should be equal to the amount of lysine leaving the pool.
Lysine can enter the pool either by being released from
proteins as result of breakdown or through diet. Lysine
leaving the pool may be either oxidative disposal or non-
oxidative disposal.
Q = I+LRP = Ox+NOLD (3)
where Q is flux of the lysine tracer (mmol/(kg6h)), LRP is the
amount of lysine released from protein via protein break-
down (mmol/(kg6h)), Ox is the rate of lysine oxidation
(mmol/(kg6h)), and NOLD is the rate of non-oxidative lysine
disposal (mmol/(kg6h)).
42 van der Schoor, Reeds, Stellaard, et al
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Net lysine balance, an index of protein deposition, was
calculated as:
B = NOLD2LRP (4)
where B is lysine balance (mmol/(kg6h)).
Whole body CO2 production was estimated as:
Body CO2 production = iB6[(EiB/IEB)21] (5)
where iB is the infusion rate of [
13C]sodium bicarbonate
(mmol/(kg6h)), EiB is enrichment (mol% excess) of
[13C]bicarbonate in the bicarbonate infusate and IEB is
13CO2 enrichment at plateau during the [
13C]sodium
bicarbonate infusion (mol% excess). This equation does not
correct for retention of [13C]bicarbonate in different body
pools and will overestimate CO2 production rate. However,
the same correction factor has to be applied to quantify the
lysine oxidation rate (eqn (6)). Consequently, lysine oxida-
tion rate is not overestimated.38
As described previously, lysine oxidation was calculated by
multiplying recovery of [13C]lysine in expiratory air with the
rate of appearance of lysine.38 The fraction of lysine oxidised
was measured according to the following equation, assuming
a constant VCO2 (rate of CO2 production) during the study,
that lasted seven hours38:
Fraction of lysine oxidised = [IEL6iB]/[IEB6iL66] (6)
where IEL and IEB are
13CO2 enrichments (mol% excess) at
steady state during intravenous [U-13C]lysine and
[13C]bicarbonate infusion. The iL is multiplied by a factor of
6 to account for the number of C atoms that are labelled.
Whole body lysine oxidation was then calculated as:
Whole body lysine oxidation = eqn (6)6eqn (1) (7)
Calculation of the metabolism of enterally administered
[U-13C]lysine to CO2 is complicated by the fact that some of
the lysine tracer is absorbed and thereby labels the arterial
pool. Thus the non-first pass oxidation of [13C]labelled lysine
that was administered enterally but was absorbed and
entered the body at study day 2 can be calculated as:
Non-first pass oxidation of enterally administered
lysine = (IE13C ig/IE13C iv)6eqn (7) (8)
where IE13C ig is the
13C enrichment (mol% excess) in plasma
during intragastric [13C]lysine infusion on study day 2, and
IE13C iv is the
13C enrichment in plasma during intravenous
[13C]lysine infusion on study day 1.
Total lysine oxidation on study day 2 is calculated as
described previously:
Total lysine oxidation = Recovery (eqn (6))6Qiv (9)
where Q iv is the flux of the intravenous [
2H4]lysine tracer
(mmol/(kg6h)).
First pass lysine oxidation can thus be calculated as:
First pass lysine oxidation = eqn (9)2eqn (8). (10)
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